Literature DB >> 16197379

Aggressive multifocal Buruli ulcer with associated osteomyelitis in an HIV-positive patient.

A Toll1, F Gallardo, M Ferran, M Gilaberte, M Iglesias, J L Gimeno, S Rondini, R M Pujol.   

Abstract

Mycobacterium ulcerans infection causes a skin disease known as Buruli ulcer (BU), a disorder manifested usually as a solitary and painless nodule or papule that progresses to massive necrotizing destruction and cutaneous ulceration. When healing occurs, it often results in disabling deformities. Buruli ulcer is considered the third most common mycobacterial disease in immunocompetent people, after tuberculosis and leprosy. Although the emergence of Buruli ulcer in Western African countries over the past decade has been dramatic, it has been scarcely reported in industrialized countries. We report a patient from Equatorial Guinea who was human immunodeficiency virus-positive, presenting aggressive and multifocal BU associated with an underlying destructive osteomyelitis, in which only an aggressive surgical approach yielded to a resolution of the disease. In a global world, with increasing migratory population fluxes, an increased awareness of dermatologists regarding the clinical, histopathological and microbiological features of BU is important in order to avoid significant delays in diagnosis and treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16197379     DOI: 10.1111/j.1365-2230.2005.01892.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  11 in total

1.  Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.

Authors:  Marie-Thérèse Ruf; Daniela Schütte; Aurélie Chauffour; Vincent Jarlier; Baohong Ji; Gerd Pluschke
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

Review 2.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

3.  Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Authors:  Alexandra G Fraga; Andrea Cruz; Teresa G Martins; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Wayne M Meyers; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

4.  Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.

Authors:  Ghislain Emmanuel Sopoh; Ange Dodji Dossou; Luc Valère Brun; Yves Thierry Barogui; Jean Gabin Houézo; Dissou Affolabi; Séverin Y Anagonou; Roch Christian Johnson; Luc Kestens; Françoise Portaels
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 5.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

6.  Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.

Authors:  Joseph Tuffour; Evelyn Owusu-Mireku; Marie-Therese Ruf; Samuel Aboagye; Grace Kpeli; Victor Akuoku; Janet Pereko; Albert Paintsil; Kofi Bonney; William Ampofo; Gerd Pluschke; Dorothy Yeboah-Manu
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

7.  Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.

Authors:  Brendon Y Chua; Timothy P Stinear; Kirstie M Mangas; Andrew H Buultjens; Jessica L Porter; Sarah L Baines; Estelle Marion; Laurent Marsollier; Nicholas J Tobias; Sacha J Pidot; Kylie M Quinn; David J Price; Katherine Kedzierska; Weiguang Zeng; David C Jackson
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

8.  Buruli ulcer lesions in HIV-positive patient.

Authors:  Kapay Kibadi; Robert Colebunders; Jean-Jacques Muyembe-Tamfum; Wayne M Meyers; Françoise Portaels
Journal:  Emerg Infect Dis       Date:  2010-04       Impact factor: 6.883

9.  Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in cameroon.

Authors:  Vanessa Christinet; Eric Comte; Laura Ciaffi; Peter Odermatt; Micaela Serafini; Annick Antierens; Ludovic Rossel; Alain-Bertrand Nomo; Patrick Nkemenang; Akoa Tsoungui; Cecile Delhumeau; Alexandra Calmy
Journal:  Open Forum Infect Dis       Date:  2014-05-21       Impact factor: 3.835

10.  Multifocal Buruli Ulcer Associated with Secondary Infection in HIV Positive Patient.

Authors:  Kassi Komenan; Ecra J Elidjé; Gbery P Ildevert; Kouassi I Yao; Kouame Kanga; Kouassi A Kouamé; Sangaré Abdoulaye; Kourouma S Hamdam; Yoboué P Yao; Kanga Jean-Marie
Journal:  Case Rep Med       Date:  2013-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.